1. Home
  2. CLDX vs ATKR Comparison

CLDX vs ATKR Comparison

Compare CLDX & ATKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • ATKR
  • Stock Information
  • Founded
  • CLDX N/A
  • ATKR 1959
  • Country
  • CLDX United States
  • ATKR United States
  • Employees
  • CLDX N/A
  • ATKR N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • ATKR Industrial Machinery/Components
  • Sector
  • CLDX Health Care
  • ATKR Miscellaneous
  • Exchange
  • CLDX Nasdaq
  • ATKR Nasdaq
  • Market Cap
  • CLDX 1.9B
  • ATKR 2.2B
  • IPO Year
  • CLDX 2008
  • ATKR 2016
  • Fundamental
  • Price
  • CLDX $24.34
  • ATKR $65.89
  • Analyst Decision
  • CLDX Buy
  • ATKR Hold
  • Analyst Count
  • CLDX 10
  • ATKR 6
  • Target Price
  • CLDX $43.80
  • ATKR $81.00
  • AVG Volume (30 Days)
  • CLDX 866.0K
  • ATKR 385.8K
  • Earning Date
  • CLDX 11-10-2025
  • ATKR 11-20-2025
  • Dividend Yield
  • CLDX N/A
  • ATKR 2.00%
  • EPS Growth
  • CLDX N/A
  • ATKR N/A
  • EPS
  • CLDX N/A
  • ATKR 3.22
  • Revenue
  • CLDX $2,599,000.00
  • ATKR $2,886,664,000.00
  • Revenue This Year
  • CLDX N/A
  • ATKR N/A
  • Revenue Next Year
  • CLDX N/A
  • ATKR N/A
  • P/E Ratio
  • CLDX N/A
  • ATKR $20.47
  • Revenue Growth
  • CLDX N/A
  • ATKR N/A
  • 52 Week Low
  • CLDX $14.40
  • ATKR $49.92
  • 52 Week High
  • CLDX $29.05
  • ATKR $97.32
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 44.59
  • ATKR 48.47
  • Support Level
  • CLDX $22.10
  • ATKR $64.34
  • Resistance Level
  • CLDX $26.85
  • ATKR $66.92
  • Average True Range (ATR)
  • CLDX 1.20
  • ATKR 1.69
  • MACD
  • CLDX -0.30
  • ATKR -0.58
  • Stochastic Oscillator
  • CLDX 36.70
  • ATKR 23.15

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About ATKR Atkore Inc.

Atkore Inc is a diversified industrials company and a manufacturer of electrical, mechanical, and safety infrastructure solutions. Atkore has two business segments; Electrical and Safety and Infrastructure. Net sales are highest in the electrical business line. The key product categories in the electrical segment are PVC conduit, steel conduit, and PVC-coated conduit, which are staples for electrical distributors. The key product categories in the safety and infrastructure segment include in-line galvanized mechanical tubes, metal framing and related fittings, and security bollards. Also, the company provides ancillary services to customers in the form of slitting and cutting structural steel sheets. Geographically, the company derives its key revenue from the United States.

Share on Social Networks: